| Financial Year |
March 31 2023 |
| Monetary Funds |
433,658,052.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,276,984.99 |
| Accounts Receivable |
19,750,152.57 |
| Advances to Suppliers |
19,564,826.42 |
| Other Receivables |
212,884,404.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
160,370,687.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
73,391,716.34 |
| Total Current Assets |
924,732,177.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,969,044.56 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
899,252,923.26 |
| Under-construction Projects |
744,000,592.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,775,583.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,590,111.60 |
| Deferred Income Tax Assets |
16,480,418.82 |
| Other Non-Current Assets |
29,687,576.54 |
| Sub-Total of Non-Current Assets |
1,922,124,651.96 |
| Total Assets |
2,846,856,829.31 |
| Short-Term Loans |
211,671,564.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
251,375,941.15 |
| Accounts Payable |
296,059,614.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,276,577.44 |
| Taxes Payable |
4,791,237.48 |
| Interest Payable |
343,273.75 |
| Dividend Payable |
-- |
| Other payables |
635,979,112.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
167,599,684.49 |
| Other Current Liabilities |
6,304,040.76 |
| Sub-Total of Current Liabilities |
1,646,292,669.51 |
| Long-term Loans |
300,408,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
640,762,878.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
58,760,961.35 |
| Deferred Income Tax Liabilities |
521,274.38 |
| Other Non-Current Liabilities |
50,590,815.57 |
| Sub-Total of Non-Current Liabilities |
1,172,883,475.89 |
| Total Liabilities |
2,819,176,145.40 |
| Paid-In Capital(Or Share Stock) |
216,000,000.00 |
| Capital Surplus |
386,833,055.90 |
| Surplus Reserve |
55,916,539.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-669,343,922.53 |
| Minority Stockholder's Interest |
43,251,979.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-15,571,295.30 |
| Owner's Equity（Stockholder's Equity） |
27,680,683.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,846,856,829.31 |
